Loading organizations...
Key people at Sofimac Partners.
Sofimac Partners is a French venture capital and private equity firm dedicated to supporting the growth and development of innovative companies and small to medium-sized enterprises. The firm provides financial backing and strategic guidance across various investment stages, from seed and startup phases through to development capital. Its core capabilities lie in identifying high-potential ventures and fostering their success within the broader market.
Established in 1977 and based in Clermont-Ferrand, France, the firm built its foundation on a commitment to regional economic dynamism. Its initial insight centered on the critical need for localized, expert financial support to enable promising businesses to scale. This approach allowed Sofimac Partners to evolve into a significant player in the French investment landscape, adapting its strategies to changing technological and market demands.
The firm primarily serves ambitious startups and established SMEs seeking crucial capital to fuel their expansion and innovative projects. Its long-term vision is to act as a catalyst for technological advancement and sustainable economic growth by nurturing a diverse portfolio of companies. Sofimac Partners aims to empower its portfolio entities to achieve market leadership and create lasting value through strategic collaboration.
Key people at Sofimac Partners.
Sofimac Partners has 5 tracked investments across 5 companies. The latest tracked deal is $19.1M Series C in ISORG in June 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 30, 2021 | ISORG | $19.1M Series C | — | Bpifrance, CEA Investment, Financi Ext{e}re Fonds Priv Ext{e}s, Integrated Systems Development, Mitsubishi Corporation, Sumitomo Chemical |
| Nov 5, 2019 | Diabeloop | $18.3M Grant / Other Equity | AIR Liquide Venture Capital, Crédit Agricole, Kreaxi, Sofimac Partners | Horizon 2020 |
| Jun 20, 2017 | Cosmo Tech | $3.0M Other Equity | Sofimac Partners | Aster Capital, BNP Paribas Développement |
| Mar 17, 2015 | Amolyt Pharma | $1.9M Other Equity | — | Cema, CR E DIT Agricole CR Eation, Octalfa, RH E Alpes CR Eation, Sham Innovation Sant, TAB Consulting |
| Oct 25, 2012 | Biom'Up | $8.8M Other Equity | — | Apicap, Aquasourca, Emmeline Ventures, InnoBio Fund, Merieux Equity Partners, Sham, Viveris Management |